{"transactions":[{"id":680561,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-08-20T20:01:28.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":6283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":6000,"derivative":{"exercise_price":381.92,"expiration_date":"2026-12-16","underlying":"Common Stock","underlying_shares":6283},"source":{"system":"sec-edgar","filing":"0001697422-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000169742226000002/edgardoc.xml","form_type":"4"}},{"id":680560,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance CFO"}}],"security":"Common Stock","published_at":"2026-08-20T20:01:28.000Z","date":"2026-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":4599,"price":813.47,"value":3741148.53,"ownership":{"direct":true},"balance_after":19984,"source":{"system":"sec-edgar","filing":"0001697422-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000169742226000002/edgardoc.xml","form_type":"4"}},{"id":680559,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance CFO"}}],"security":"Common Stock","published_at":"2026-08-20T20:01:28.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":6283,"price":381.92,"value":2399603.36,"ownership":{"direct":true},"balance_after":24583,"source":{"system":"sec-edgar","filing":"0001697422-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000169742226000002/edgardoc.xml","form_type":"4"}},{"id":976901,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-12-09T21:08:22.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":14924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":14924,"derivative":{"exercise_price":726.71,"expiration_date":"2035-12-05","underlying":"Common Stock","underlying_shares":14924},"source":{"system":"sec-edgar","filing":"0001697422-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000169742225000004/edgardoc.xml","form_type":"4"}},{"id":976900,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance CFO"}}],"security":"Common Stock","published_at":"2025-12-09T21:08:22.000Z","date":"2025-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":992,"price":712.94,"value":707236.48,"ownership":{"direct":true},"balance_after":18300,"source":{"system":"sec-edgar","filing":"0001697422-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000169742225000004/edgardoc.xml","form_type":"4"}},{"id":976899,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance CFO"}}],"security":"Common Stock","published_at":"2025-12-09T21:08:22.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":3027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029."}],"balance_after":19292,"source":{"system":"sec-edgar","filing":"0001697422-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000169742225000004/edgardoc.xml","form_type":"4"}},{"id":1327430,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-12-18T21:01:20.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":491,"price":730.81,"value":358827.71,"ownership":{"direct":true},"balance_after":16265,"source":{"system":"sec-edgar","filing":"0001883850-24-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000061/edgardoc.xml","form_type":"4"}},{"id":1338118,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-12-10T21:03:32.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":9979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":9979,"derivative":{"exercise_price":771.64,"expiration_date":"2034-12-06","underlying":"Common Stock","underlying_shares":9979},"source":{"system":"sec-edgar","filing":"0001883850-24-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000050/edgardoc.xml","form_type":"4"}},{"id":1338117,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:32.000Z","date":"2024-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1140,"price":787,"value":897180.0,"ownership":{"direct":true},"balance_after":16756,"source":{"system":"sec-edgar","filing":"0001883850-24-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000050/edgardoc.xml","form_type":"4"}},{"id":1338116,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:32.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":2591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028."}],"balance_after":17896,"source":{"system":"sec-edgar","filing":"0001883850-24-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000050/edgardoc.xml","form_type":"4"}},{"id":1420355,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":200,"price":1206.67,"value":241334.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":25,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420354,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":235,"price":1205.67,"value":283332.45,"ownership":{"direct":false,"nature":"by Trust for Son"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":225,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420353,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":200,"price":1206.7,"value":241340.0,"ownership":{"direct":false,"nature":"by Trust for Daugh"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":25,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420352,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":236,"price":1205.67,"value":284538.12,"ownership":{"direct":false,"nature":"by Trust for Daugh"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":225,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420351,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":450,"price":1206.15,"value":542767.5,"ownership":{"direct":false,"nature":"2022 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420350,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":928,"price":1205.49,"value":1118694.72,"ownership":{"direct":false,"nature":"2022 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":450,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420349,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":2237,"price":1204.71,"value":2694936.27,"ownership":{"direct":false,"nature":"2022 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":1378,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420348,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":200,"price":1206.3,"value":241260.0,"ownership":{"direct":false,"nature":"2021 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420347,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":766,"price":1205.44,"value":923367.04,"ownership":{"direct":false,"nature":"2021 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1420346,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-08-29T20:27:40.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":228,"price":1204.79,"value":274692.12,"ownership":{"direct":false,"nature":"2021 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price."}],"balance_after":966,"source":{"system":"sec-edgar","filing":"0001883850-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/edgardoc.xml","form_type":"4"}},{"id":1650335,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-02-12T21:02:02.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":600,"price":955,"value":573000.0,"ownership":{"direct":true},"balance_after":14372,"source":{"system":"sec-edgar","filing":"0001968202-24-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000061/edgardoc.xml","form_type":"4"}},{"id":1650334,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-02-12T21:02:02.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":1100,"price":954.57,"value":1050027.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 1,100 shares of Company stock on February 9, 2024 at prices ranging from $954.00 to $954.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price."}],"balance_after":14972,"source":{"system":"sec-edgar","filing":"0001968202-24-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000061/edgardoc.xml","form_type":"4"}},{"id":1650333,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-02-12T21:02:02.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":1342,"price":953.47,"value":1279556.74,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 1,342 shares of Company stock on February 9, 2024 at prices ranging from $953.02 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price."}],"balance_after":16072,"source":{"system":"sec-edgar","filing":"0001968202-24-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000061/edgardoc.xml","form_type":"4"}},{"id":1650332,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-02-12T21:02:02.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":1046,"price":952.62,"value":996440.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 1,046 shares of Company stock on February 9, 2024 at prices ranging from $952.11 to $952.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price."}],"balance_after":17414,"source":{"system":"sec-edgar","filing":"0001968202-24-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000061/edgardoc.xml","form_type":"4"}},{"id":1650331,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-02-12T21:02:02.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":487,"price":951.39,"value":463326.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 487 shares of Company stock on February 9, 2024 at prices ranging from $951.03 to $951.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price."}],"balance_after":18460,"source":{"system":"sec-edgar","filing":"0001968202-24-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000061/edgardoc.xml","form_type":"4"}},{"id":1650330,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & CFO"}}],"security":"Common Stock","published_at":"2024-02-12T21:02:02.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":344,"price":950.49,"value":326968.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 344 shares of Company stock on February 9, 2024 at prices ranging from $950.33 to $950.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price."}],"balance_after":18947,"source":{"system":"sec-edgar","filing":"0001968202-24-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000061/edgardoc.xml","form_type":"4"}},{"id":1671437,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-25T21:17:49.000Z","date":"2024-01-23","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":555.67,"expiration_date":"2025-12-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001968202-24-000041","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000041/edgardoc.xml","form_type":"4"}},{"id":1671436,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-25T21:17:49.000Z","date":"2024-01-23","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":399.66,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001968202-24-000041","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000041/edgardoc.xml","form_type":"4"}},{"id":1671435,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2024-01-25T21:17:49.000Z","date":"2024-01-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3583,"price":948.5,"value":3398475.5,"ownership":{"direct":true},"balance_after":19291,"source":{"system":"sec-edgar","filing":"0001968202-24-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000041/edgardoc.xml","form_type":"4"}},{"id":1671434,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2024-01-25T21:17:49.000Z","date":"2024-01-23","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":399.66,"value":1998300.0,"ownership":{"direct":true},"balance_after":22874,"source":{"system":"sec-edgar","filing":"0001968202-24-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000041/edgardoc.xml","form_type":"4"}},{"id":1671433,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2024-01-25T21:17:49.000Z","date":"2024-01-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3986,"price":948.5,"value":3780721.0,"ownership":{"direct":true},"balance_after":17874,"source":{"system":"sec-edgar","filing":"0001968202-24-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000041/edgardoc.xml","form_type":"4"}},{"id":1671432,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2024-01-25T21:17:49.000Z","date":"2024-01-23","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":555.67,"value":2778350.0,"ownership":{"direct":true},"balance_after":21860,"source":{"system":"sec-edgar","filing":"0001968202-24-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000041/edgardoc.xml","form_type":"4"}},{"id":1689494,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:22:04.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":555.67,"expiration_date":"2025-12-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001883850-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000008/edgardoc.xml","form_type":"4"}},{"id":1689493,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:22:04.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":399.66,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001883850-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000008/edgardoc.xml","form_type":"4"}},{"id":1689492,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2024-01-04T21:22:04.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3469,"price":912.3,"value":3164768.7,"ownership":{"direct":true},"balance_after":16860,"source":{"system":"sec-edgar","filing":"0001883850-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000008/edgardoc.xml","form_type":"4"}},{"id":1689491,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2024-01-04T21:22:04.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":399.66,"value":1998300.0,"ownership":{"direct":true},"balance_after":20329,"source":{"system":"sec-edgar","filing":"0001883850-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000008/edgardoc.xml","form_type":"4"}},{"id":1689490,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2024-01-04T21:22:04.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4043,"price":912.3,"value":3688428.9,"ownership":{"direct":true},"balance_after":15329,"source":{"system":"sec-edgar","filing":"0001883850-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000008/edgardoc.xml","form_type":"4"}},{"id":1689489,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2024-01-04T21:22:04.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":555.67,"value":2778350.0,"ownership":{"direct":true},"balance_after":19372,"source":{"system":"sec-edgar","filing":"0001883850-24-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000008/edgardoc.xml","form_type":"4"}},{"id":1698246,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-29T21:04:51.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":2448,"price":856.71,"value":2097226.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 25, 2023."}],"balance_after":14372,"source":{"system":"sec-edgar","filing":"0001883850-23-000107","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000107/edgardoc.xml","form_type":"4"}},{"id":1700456,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-26T21:08:29.000Z","date":"2023-12-22","kind":"sale","planned":true,"acquired":false,"shares":250,"price":846.27,"value":211567.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 25, 2023."}],"balance_after":16820,"source":{"system":"sec-edgar","filing":"0001883850-23-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000103/edgardoc.xml","form_type":"4"}},{"id":1700455,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-26T21:08:29.000Z","date":"2023-12-21","kind":"sale","planned":true,"acquired":false,"shares":1224,"price":844.09,"value":1033166.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 25, 2023."}],"balance_after":17070,"source":{"system":"sec-edgar","filing":"0001883850-23-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000103/edgardoc.xml","form_type":"4"}},{"id":1700454,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-26T21:08:29.000Z","date":"2023-12-21","kind":"sale","planned":true,"acquired":false,"shares":456,"price":843.79,"value":384768.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 25, 2023."}],"balance_after":18294,"source":{"system":"sec-edgar","filing":"0001883850-23-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000103/edgardoc.xml","form_type":"4"}},{"id":1711607,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-14T21:08:17.000Z","date":"2023-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":2552,"price":856.71,"value":2186323.92,"ownership":{"direct":true},"balance_after":18750,"source":{"system":"sec-edgar","filing":"0001883850-23-000101","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000101/edgardoc.xml","form_type":"4"}},{"id":1715269,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-12-12T21:01:25.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":8499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":8499,"derivative":{"exercise_price":843.79,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":8499},"source":{"system":"sec-edgar","filing":"0001968202-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000050/edgardoc.xml","form_type":"4"}},{"id":1715268,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-12T21:01:25.000Z","date":"2023-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":260,"price":844.09,"value":219463.4,"ownership":{"direct":true},"balance_after":21302,"source":{"system":"sec-edgar","filing":"0001968202-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000050/edgardoc.xml","form_type":"4"}},{"id":1715267,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-12T21:01:25.000Z","date":"2023-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1276,"price":844.09,"value":1077058.84,"ownership":{"direct":true},"balance_after":21562,"source":{"system":"sec-edgar","filing":"0001968202-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000050/edgardoc.xml","form_type":"4"}},{"id":1715266,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-12T21:01:25.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":2370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2025 and 50% on December 8, 2027."}],"balance_after":22838,"source":{"system":"sec-edgar","filing":"0001968202-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000050/edgardoc.xml","form_type":"4"}},{"id":1715265,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-12-12T21:01:25.000Z","date":"2023-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":474,"price":843.79,"value":399956.46,"ownership":{"direct":true},"balance_after":20468,"source":{"system":"sec-edgar","filing":"0001968202-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000050/edgardoc.xml","form_type":"4"}},{"id":1797084,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-08-25T20:03:11.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":399.66,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001968202-23-000031","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000031/edgardoc.xml","form_type":"4"}},{"id":1797083,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-08-25T20:03:11.000Z","date":"2023-08-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":5198,"price":842.66,"value":4380146.68,"ownership":{"direct":true},"balance_after":20942,"source":{"system":"sec-edgar","filing":"0001968202-23-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000031/edgardoc.xml","form_type":"4"}},{"id":1797082,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-08-25T20:03:11.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":true,"shares":7000,"price":399.66,"value":2797620.0,"ownership":{"direct":true},"balance_after":26140,"source":{"system":"sec-edgar","filing":"0001968202-23-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000031/edgardoc.xml","form_type":"4"}},{"id":1938434,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-03-27T20:37:48.000Z","date":"2023-03-23","kind":"sale","planned":true,"acquired":false,"shares":2192,"price":806.47,"value":1767782.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 9, 2023."}],"balance_after":18409,"source":{"system":"sec-edgar","filing":"0001883850-23-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000060/edgardoc.xml","form_type":"4"}},{"id":2029491,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-02-07T21:10:43.000Z","date":"2023-02-03","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":270.43,"expiration_date":"2023-12-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001883850-23-000037","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000037/edgardoc.xml","form_type":"4"}},{"id":2029490,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-02-07T21:10:43.000Z","date":"2023-02-03","kind":"tax_withholding","acquired":false,"shares":3286,"price":774.29,"value":2544316.94,"ownership":{"direct":true},"balance_after":20295,"source":{"system":"sec-edgar","filing":"0001883850-23-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000037/edgardoc.xml","form_type":"4"}},{"id":2029489,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2023-02-07T21:10:43.000Z","date":"2023-02-03","kind":"exercise","acquired":true,"shares":5000,"price":270.43,"value":1352150.0,"ownership":{"direct":true},"balance_after":23581,"source":{"system":"sec-edgar","filing":"0001883850-23-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000037/edgardoc.xml","form_type":"4"}},{"id":2080308,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-20T21:06:42.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":7111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":7111,"derivative":{"exercise_price":726.53,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":7111},"source":{"system":"sec-edgar","filing":"0001883850-22-000131","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000131/edgardoc.xml","form_type":"4"}},{"id":2080307,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-12-20T21:06:42.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":1926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026."}],"balance_after":18581,"source":{"system":"sec-edgar","filing":"0001883850-22-000131","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000131/edgardoc.xml","form_type":"4"}},{"id":2088760,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-12-13T21:09:56.000Z","date":"2022-10-26","kind":"gift","acquired":true,"shares":435,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"balance_after":460,"source":{"system":"sec-edgar","filing":"0001883850-22-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000117/edgardoc.xml","form_type":"4"}},{"id":2088759,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-12-13T21:09:56.000Z","date":"2022-10-26","kind":"gift","acquired":true,"shares":436,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust for Daugh"},"balance_after":461,"source":{"system":"sec-edgar","filing":"0001883850-22-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000117/edgardoc.xml","form_type":"4"}},{"id":2088758,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-12-13T21:09:56.000Z","date":"2022-10-26","kind":"gift","acquired":false,"shares":871,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by 2018 GRAT"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001883850-22-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000117/edgardoc.xml","form_type":"4"}},{"id":2088757,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-12-13T21:09:56.000Z","date":"2022-12-09","kind":"tax_withholding","acquired":false,"shares":247,"price":753.28,"value":186060.16,"ownership":{"direct":true},"balance_after":16655,"source":{"system":"sec-edgar","filing":"0001883850-22-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000117/edgardoc.xml","form_type":"4"}},{"id":2140829,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-10-07T20:03:05.000Z","date":"2022-10-05","kind":"sale","acquired":false,"shares":1844,"price":749,"value":1381156.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":16425,"source":{"system":"sec-edgar","filing":"0001883850-22-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000080/edgardoc.xml","form_type":"4"}},{"id":2142969,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-10-05T20:10:31.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":3346,"price":724,"value":2422504.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":18269,"source":{"system":"sec-edgar","filing":"0001883850-22-000077","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000077/edgardoc.xml","form_type":"4"}},{"id":2299679,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-11T20:40:03.000Z","date":"2022-04-08","kind":"exercise","acquired":false,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":555.67,"expiration_date":"2025-12-16","underlying":"Common Stock","underlying_shares":2450},"source":{"system":"sec-edgar","filing":"0001708138-22-000039","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000039/edgardoc.xml","form_type":"4"}},{"id":2299678,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-11T20:40:03.000Z","date":"2022-04-08","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":270.43,"expiration_date":"2023-12-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001708138-22-000039","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000039/edgardoc.xml","form_type":"4"}},{"id":2299677,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-04-11T20:40:03.000Z","date":"2022-04-08","kind":"tax_withholding","acquired":false,"shares":3451,"price":736.21,"value":2540660.71,"ownership":{"direct":true},"balance_after":26615,"source":{"system":"sec-edgar","filing":"0001708138-22-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000039/edgardoc.xml","form_type":"4"}},{"id":2299676,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-04-11T20:40:03.000Z","date":"2022-04-08","kind":"exercise","acquired":true,"shares":5000,"price":270.43,"value":1352150.0,"ownership":{"direct":true},"balance_after":30066,"source":{"system":"sec-edgar","filing":"0001708138-22-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000039/edgardoc.xml","form_type":"4"}},{"id":2299675,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-04-11T20:40:03.000Z","date":"2022-04-08","kind":"tax_withholding","acquired":false,"shares":2155,"price":736.21,"value":1586532.55,"ownership":{"direct":true},"balance_after":25066,"source":{"system":"sec-edgar","filing":"0001708138-22-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000039/edgardoc.xml","form_type":"4"}},{"id":2299674,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-04-11T20:40:03.000Z","date":"2022-04-08","kind":"exercise","acquired":true,"shares":2450,"price":555.67,"value":1361391.5,"ownership":{"direct":true},"balance_after":27221,"source":{"system":"sec-edgar","filing":"0001708138-22-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000039/edgardoc.xml","form_type":"4"}},{"id":2311958,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-01T20:07:40.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":12450,"derivative":{"exercise_price":555.67,"expiration_date":"2025-12-16","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001883850-22-000029","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000029/edgardoc.xml","form_type":"4"}},{"id":2311957,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-01T20:07:40.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":270.43,"expiration_date":"2023-12-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001883850-22-000029","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000029/edgardoc.xml","form_type":"4"}},{"id":2311956,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-04-01T20:07:40.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":6857,"price":700.99,"value":4806688.43,"ownership":{"direct":true},"balance_after":24771,"source":{"system":"sec-edgar","filing":"0001883850-22-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000029/edgardoc.xml","form_type":"4"}},{"id":2311955,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-04-01T20:07:40.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":10000,"price":270.43,"value":2704300.0,"ownership":{"direct":true},"balance_after":31628,"source":{"system":"sec-edgar","filing":"0001883850-22-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000029/edgardoc.xml","form_type":"4"}},{"id":2311954,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-04-01T20:07:40.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":1797,"price":700.99,"value":1259679.03,"ownership":{"direct":true},"balance_after":21628,"source":{"system":"sec-edgar","filing":"0001883850-22-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000029/edgardoc.xml","form_type":"4"}},{"id":2311953,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2022-04-01T20:07:40.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":2000,"price":555.67,"value":1111340.0,"ownership":{"direct":true},"balance_after":23425,"source":{"system":"sec-edgar","filing":"0001883850-22-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000029/edgardoc.xml","form_type":"4"}},{"id":2474346,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-12-14T21:10:29.000Z","date":"2021-12-11","kind":"tax_withholding","acquired":false,"shares":270,"price":664.34,"value":179371.8,"ownership":{"direct":true},"balance_after":21122,"source":{"system":"sec-edgar","filing":"0001708138-21-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000106/edgardoc.xml","form_type":"4"}},{"id":2477909,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-10T22:28:50.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":7941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":7941,"derivative":{"exercise_price":644.54,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":7941},"source":{"system":"sec-edgar","filing":"0001883850-21-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000022/edgardoc.xml","form_type":"4"}},{"id":2477908,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-12-10T22:28:50.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":1859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025."}],"balance_after":21392,"source":{"system":"sec-edgar","filing":"0001883850-21-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000022/edgardoc.xml","form_type":"4"}},{"id":2591534,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-25T20:06:40.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":8719,"price":664.85,"value":5796827.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities shown following the reported transaction gives effect to the other transactions reported by the Reporting Person in the Original Form 4."}],"balance_after":19020,"source":{"system":"sec-edgar","filing":"0001104659-21-109328","document":"tm2125915-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000110465921109328/tm2125915-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-08-24"}},{"id":2592902,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-20","kind":"exercise","acquired":false,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2592901,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":14,"price":665.21,"value":9312.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":27739,"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2592900,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":70,"price":663.05,"value":46413.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 70 shares of Company stock on August 23, 2021 at prices ranging from $663.00 to $663.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price."}],"balance_after":27753,"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2592899,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":1,"price":662.78,"value":662.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":27823,"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2592898,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":88,"price":661.89,"value":58246.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 88 shares of Company stock on August 23, 2021 at prices ranging from $661.47 to $661.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price."}],"balance_after":27824,"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2592897,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":23,"price":660.33,"value":15187.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 23 shares of Company stock on August 23, 2021 at prices ranging from $660.09 to $660.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price."}],"balance_after":27912,"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2592896,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":9,"price":659.33,"value":5933.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 9 shares of Company stock on August 23, 2021 at prices ranging from $659.28 to $659.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price."}],"balance_after":27935,"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2592895,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":4576,"price":655,"value":2997280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":27944,"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2592894,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Controller"}}],"security":"Common Stock","published_at":"2021-08-24T20:04:45.000Z","date":"2021-08-20","kind":"exercise","acquired":true,"shares":13500,"price":179.13,"value":2418255.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":32520,"source":{"system":"sec-edgar","filing":"0001237899-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000017/edgardoc.xml","form_type":"4"}},{"id":2949270,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-12-11T21:05:25.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":492,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001708138-20-000113","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000113/edgardoc.xml","form_type":"4"}},{"id":2949269,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-12-11T21:05:25.000Z","date":"2020-09-24","kind":"gift","acquired":true,"shares":25,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"balance_after":25,"source":{"system":"sec-edgar","filing":"0001708138-20-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000113/edgardoc.xml","form_type":"4"}},{"id":2949268,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-12-11T21:05:25.000Z","date":"2020-09-24","kind":"gift","acquired":true,"shares":25,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust for Daugh"},"balance_after":25,"source":{"system":"sec-edgar","filing":"0001708138-20-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000113/edgardoc.xml","form_type":"4"}},{"id":2949267,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-12-11T21:05:25.000Z","date":"2020-09-24","kind":"gift","acquired":false,"shares":50,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by 2017 GRAT"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001708138-20-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000113/edgardoc.xml","form_type":"4"}},{"id":2949266,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-12-11T21:05:25.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 9, 2024."}],"balance_after":21102,"source":{"system":"sec-edgar","filing":"0001708138-20-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000113/edgardoc.xml","form_type":"4"}},{"id":2949265,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-12-11T21:05:25.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024."}],"balance_after":19352,"source":{"system":"sec-edgar","filing":"0001708138-20-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000113/edgardoc.xml","form_type":"4"}},{"id":3078325,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-22T20:31:48.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":13500,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001237899-20-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000035/edgardoc.xml","form_type":"4"}},{"id":3078324,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-07-22T20:31:48.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":2224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":2224},"source":{"system":"sec-edgar","filing":"0001237899-20-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000035/edgardoc.xml","form_type":"4"}},{"id":3078323,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-07-22T20:31:48.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":11,"price":658,"value":7238.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":17501,"source":{"system":"sec-edgar","filing":"0001237899-20-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000035/edgardoc.xml","form_type":"4"}},{"id":3078322,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-07-22T20:31:48.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":82,"price":647.79,"value":53118.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":17512,"source":{"system":"sec-edgar","filing":"0001237899-20-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000035/edgardoc.xml","form_type":"4"}},{"id":3078321,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-07-22T20:31:48.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":155,"price":646.82,"value":100257.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 155 shares of Company stock on July 21, 2020 at prices ranging from $646.71 to $646.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 21, 2020 at each separate price."}],"balance_after":17594,"source":{"system":"sec-edgar","filing":"0001237899-20-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000035/edgardoc.xml","form_type":"4"}},{"id":3078320,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":21402,"kind":"person","name":"Fenimore Christopher R.","position":1,"cik":"0001697422","reported_name":"Fenimore Christopher R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller"}}],"security":"Common Stock","published_at":"2020-07-22T20:31:48.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":72,"price":645.33,"value":46463.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":17749,"source":{"system":"sec-edgar","filing":"0001237899-20-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000035/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-07-22T20:31:48.000000Z,3078320"}